Back

Myocardial fibrosis and outcome in aortic stenosis: a CMR and circulating biomarker study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Myocardial damage and aortic stenosis: a close interplay Aortic Valve Stenosis ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Associate Professor Arantxa Gonzalez Miqueo

Clinic University of Navarra, Pamplona (Spain)

6 More presentations in this session

Presentation thumbnail
Cardiac damage stages and clinical outcomes in patients with severe aortic stenosis
Doctor Y. Takeji (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Evaluating the impact of left ventricular end-systolic elastance on aortic stenosis
Doctor E. Thong (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Comparative outcomes of early intervention vs. watchful waiting strategy for moderate aortic stenosis by extent of extra-valvular cardiac damage
Doctor J. Lim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of heart failure as an indication for intervention in severe aortic stenosis
Miss A. Cristea (Valladolid, ES)
Abstract Slides Video
Presentation thumbnail
Impact, prognostic implications and treatment trends of aortic stenosis across the heart failure spectrum
Doctor G. Heitzinger (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial damage and aortic stenosis: a close interplay

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Limitations of traditional aortic stenosis classification: myocardial fibrosis across AS subtypes assessed by cardiac magnetic resonance.
thumbnail
Congress Presentation
Postoperative assessment of interstitial myocardial fibrosis in aortic valve pathologies: insights from a cardiac magnetic resonance study
thumbnail
Congress Presentation
Histopathological myocardial changes in patients with severe aortic stenosis referred for surgical valve replacement: a CMR correlation study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources